Results

• All
• Video
• Audio
• Images

• Most recent

1–1 of 1 result for Michael W. Stewart

• 

  Open-Label Study Evaluating the Effects of the CCR3 Antagonist ALK4290 in Patients With Neovascular AMD Refractory to Anti-VEGF Therapy

  Michael W. Stewart, MD

  Annual Meeting Talks

  2019